A

Alnylam Pharmaceuticals

Cambridge, United States Founded 2002 NASDAQ: ALNY

About

Pioneer in RNAi therapeutics using lipid nanoparticle delivery for treatment of genetic diseases

Company Details

Type
commercial
Employees
1000+
Funding
Public

Key Products

  • Onpattro
  • Givlaari
  • Oxlumo
Visit Website

Related Companies